# Vasopressors for Cerebral Oxygenation

> **NCT02009007** · PHASE1 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Hypoxia
- Hypotension

## Interventions

- **DRUG:** dopamine
- **DRUG:** phenylephrine

## Key facts

- **NCT ID:** NCT02009007
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2014-06
- **Final completion:** 2014-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02009007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02009007, "Vasopressors for Cerebral Oxygenation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02009007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*